By Penn Today –
Laboratory studies reveal a potentially low-tech intervention to improve personalized cell therapy.
A simple dietary supplement may provide a new approach to boost CAR T cell function, according to a study from researchers in Penn’s Perelman School of Medicine (PSOM) and Penn Medicine’s Abramson Cancer Center. While the approach needs to be assessed in clinical trials, the early research, shared in a press briefing on Dec. 7 at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition (Abstract 4), hints at a potentially cost-effective strategy to improve CAR T cell function and cancer-fighting abilities.
